glp 1 conversion chart Injectable GLP-1 Receptor Agonists Switching Between Glucagon-Like Peptide-1 Receptor

A major growth factor for Saxenda is the increasing awareness and emphasis on obesity as a medical condition requiring pharmacological intervention alongside lifestyle modifications

Peripheral administration of lactate produces antidepressant-like effects

Effective interventions in preventing gestational diabetes mellitus: a systematic review and meta-analysis

Mounjaro and Vision Changes 2026 Update July 2026: There are currently 146 pending claims in the MDL for patients alleging that GLP-1 drugs, including Mounjaro, led them to develop NAION (vision loss)

Since gastric distension (both of the proximal and distal stomach) can lead to reduced food/energy intake (64, 65), the question arises as to whether the slowing of gastric emptying, via increased gastric distension, contributes to the regulation of appetite and energy intake

In humans, nearly all circulating GLP-1 is one of the latter two forms (89)